Thiadiazolidinones as GSK-3 inhibitors

Details for Australian Patent Application No. 2005230392 (hide)

Owner Noscira S.A.

Inventors Fuertes Huerta, Ana; Alonso Cascon, Mercedes; Dorronsoro Diaz, Isabel; Perez Puerto, Maria Jose; Panizo Del Pliego, Gema; Medina Padilla, Miguel; Martinez Gil, Ana

Agent Fisher Adams Kelly

Pub. Number AU-B-2005230392

PCT Pub. Number WO2005/097117

Priority 04075997.9 05.04.04 EP

Filing date 4 April 2005

Wipo publication date 20 October 2005

Acceptance publication date 24 March 2011

International Classifications

C07D 285/08 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097117 Priority application(s): WO2005/097117

3 December 2009 Amendment Made

  The nature of the amendment is: Amend the applicant name from Neuropharma, S.A. to Noscira S.A.

24 March 2011 Application Accepted

  Published as AU-B-2005230392

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230397-Intermittent dosing regimen for the treatment of overweight with MTPinhibitors

2005230388-Use of 9H-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9H-purine-2,6-diamine derivatives